O:8:”stdClass”:47:{s:9:”PrimaryId”;s:10:”1861564304″;s:12:”AlternateId1″;s:0:””;s:12:”AlternateId2″;s:0:””;s:12:”AlternateId3″;s:0:””;s:12:”AlternateId4″;s:0:””;s:9:”IsEnabled”;s:1:”1″;s:9:”is_select”;s:1:”1″;s:11:”IsPreferred”;s:1:”1″;s:9:”DirectURL”;s:0:””;s:6:”avatar”;s:66:”https://ct1.medstarhealth.org/content/uploads/2015/06/Dr-Faust.jpg”;s:11:”name_prefix”;s:3:”Dr.”;s:10:”name_first”;s:6:”Thomas”;s:11:”name_middle”;s:6:”Wilson”;s:9:”name_last”;s:5:”Faust”;s:11:”name_suffix”;s:2:”MD”;s:6:”gender”;s:4:”Male”;s:13:”date_of_birth”;s:10:”08/08/1956″;s:17:”in_practice_since”;s:0:””;s:5:”email”;s:0:””;s:14:”personal_email”;s:0:””;s:7:”website”;s:0:””;s:15:”appointment_url”;s:0:””;s:11:”is_featured”;b:0;s:5:”phone”;O:8:”stdClass”:2:{s:5:”voice”;s:14:”(202) 444-3700″;s:3:”fax”;s:14:”(877) 680-8192″;}s:19:”patient_preferences”;a:0:{}s:14:”provider_types”;a:0:{}s:8:”about_me”;s:1675:”

Board-certified in internal medicine, gastroenterology and transplant, Thomas W. Faust, MD, MBE, specializes in the management of patients with acute and chronic liver diseases, as well as patients who have undergone liver transplantation. His research interests include the use of bio-artificial liver support devices, treatments for patients with viral hepatitis and autoimmune liver diseases, management of acute liver failure and bioethical implications of liver transplantation.

Previously, Dr. Faust served as Director of Hepatology at the Medical College of Wisconsin, Medical Director of Liver Transplantation and Primary Liver Transplant Physician for UNOS, Milwaukee, Wisconsin.

After receiving a medical degree from the University of Tennessee College of Medicine, Dr. Faust completed a residency in internal medicine at Yale-New Haven Hospital. He followed that with a fellowship in Gastroenterology at the University of Texas Southwestern Medical Center at Dallas and a fellowship in Hepatology and Liver Transplantation at the University of Nebraska Medical Center. Most recently, he received a Masters in Bioethics from the University of Pennsylvania School of Medicine.

Dr. Faust’s Philosophy of Care

Beyond my years of medical training and experience, I also earned a Masters degree in Bioethics from the University of Pennsylvania School of Medicine. As a result, I view each patient within a holistic and ethically appropriate framework.  I believe that approach interjects an additional level of compassion, understanding and humanity into my relationships and dealings with patients, their family and caregivers.

“;s:18:”philosophy_of_care”;s:0:””;s:22:”additional_information”;s:0:””;s:9:”languages”;a:1:{i:0;O:8:”stdClass”:2:{s:4:”name”;s:7:”English”;s:11:”proficiency”;s:16:”Primary Language”;}}s:10:”educations”;a:6:{i:0;O:8:”stdClass”:3:{s:4:”type”;s:15:”Graduate School”;s:4:”year”;s:4:”2007″;s:8:”location”;s:45:”University of Pennsylvania School of Medicine”;}i:1;O:8:”stdClass”:3:{s:4:”type”;s:18:”Fellowship Program”;s:4:”year”;s:4:”1997″;s:8:”location”;s:37:”University of Nebraska Medical Center”;}i:2;O:8:”stdClass”:3:{s:4:”type”;s:18:”Fellowship Program”;s:4:”year”;s:4:”1989″;s:8:”location”;s:48:”University of Texas, Southwestern Medical School”;}i:3;O:8:”stdClass”:3:{s:4:”type”;s:17:”Residency Program”;s:4:”year”;s:4:”1986″;s:8:”location”;s:23:”Yale New Haven Hospital”;}i:4;O:8:”stdClass”:3:{s:4:”type”;s:18:”Internship Program”;s:4:”year”;s:4:”1984″;s:8:”location”;s:23:”Yale New Haven Hospital”;}i:5;O:8:”stdClass”:3:{s:4:”type”;s:14:”Medical School”;s:4:”year”;s:4:”1983″;s:8:”location”;s:43:”University of Tennessee College of Medicine”;}}s:6:”videos”;a:1:{i:0;O:8:”stdClass”:1:{s:3:”url”;s:28:”https://youtu.be/Wz3jAJCbnG0″;}}s:12:”VideoContent”;N;s:11:”specialties”;a:2:{i:0;O:8:”stdClass”:7:{s:10:”primary_id”;s:0:””;s:4:”name”;s:16:”Gastroenterology”;s:7:”primary”;b:0;s:15:”board_certified”;b:0;s:10:”board_name”;s:0:””;s:19:”verification_notice”;s:0:””;s:18:”certification_year”;s:0:””;}i:1;O:8:”stdClass”:7:{s:10:”primary_id”;s:0:””;s:4:”name”;s:21:”Transplant Hepatology”;s:7:”primary”;b:1;s:15:”board_certified”;b:1;s:10:”board_name”;s:0:””;s:19:”verification_notice”;s:0:””;s:18:”certification_year”;s:0:””;}}s:10:”rich_texts”;a:0:{}s:6:”awards”;a:2:{i:0;O:8:”stdClass”:1:{s:4:”name”;s:23:”Best Doctors in America”;}i:1;O:8:”stdClass”:1:{s:4:”name”;s:24:”Multiple teaching awards”;}}s:20:”health_organizations”;a:0:{}s:24:”professional_memberships”;a:2:{i:0;O:8:”stdClass”:1:{s:4:”name”;s:40:”American Gastroenterological Association”;}i:1;O:8:”stdClass”:1:{s:4:”name”;s:52:”American Association for the Study of Liver Diseases”;}}s:13:”social_medias”;a:0:{}s:14:”certifications”;a:0:{}s:9:”researchs”;a:0:{}s:12:”publications”;a:5:{i:0;O:8:”stdClass”:4:{s:4:”type”;s:6:”Online”;s:4:”date”;s:10:”09/01/2015″;s:3:”url”;s:44:”https://www.ncbi.nlm.nih.gov/pubmed/26422271″;s:8:”abstract”;s:1930:”Project P.E.A.C.H. (Pathway and Education Toward Adherence and Completion in Hepatitis C Therapy): A Nurse-Driven Evidence-Based Protocol. Chronic hepatitis C virus (HCV) remains a major healthcare concern. The 24-48 week treatment of pegylated interferon and ribavirin therapy requires a tremendous amount of commitment from patients and providers. Thus, there has been a huge focus on health-related quality of life and various measures to support patient adherence and completion of the recommended HCV treatment regimen. This quality improvement project aimed to develop and test a nurse-driven evidence-based pathway that supports the care of patients receiving hepatitis C medication therapy in a tertiary, academic hepatology practice. All adult patients, 18 years and older, who were started on HCV treatment from January 20 to February 15, 2011, were included in the testing of a nurse-driven HCV pathway for the first 12 weeks of treatment. The majority of the patients treated were male (71.8% prepathway and 83.3% postpathway), of White ethnic background (61.5% prepathway and 58.3% postpathway), genotype 1 (69% prepathway and 91.7% postpathway), and had comorbid conditions classified as “other” (38.5% prepathway and 33.3% postpathway). As for treatment status, the majority of the patients were “treatment naive” in prepathway or had never received prior HCV treatment (59.0%) or “had recurrent HCV after liver transplantation” (41.7%). The 4-week treatment completion rate was 94.9% for the prepathway group and 100.0% for the postpathway group; 12-week completion rate was 87.2% (prepathway) and 58.3% for the postpathway group. The mean 4-week adherence score for the prepathway group was 2.46 and the postpathway group was 2.92. Mean lag time to treatment was decreased with 26 days in the postpathway and 43 in the prepathway. Providers and nurses expressed overall satisfaction with the nurse-driven pathway.”;}i:1;O:8:”stdClass”:4:{s:4:”type”;s:6:”Online”;s:4:”date”;s:10:”06/26/2013″;s:3:”url”;s:44:”https://www.ncbi.nlm.nih.gov/pubmed/23551167″;s:8:”abstract”;s:1494:”Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients. Post-transplant lymphoproliferative disorder (PTLD) is a serious complication of organ transplantation. Although PTLD typically has a B-cell histology, an uncommon variant, plasmacytic PTLD can present as a monoclonal plasma cell proliferation similar to plasmacytomas seen in multiple myeloma. A retrospective analysis was performed on nine patients at our center with plasmacytic PTLD as characterized by plasmacytic histology with the presence of CD138 and lack of CD20. Of the 210 adult solid organ transplant PTLD patients diagnosed between 1988 and 2012, 9 (4%) had a histological appearance consistent with plasmacytic PTLD. The median time from transplant to diagnosis was 3.7 years (range 8 months-24 years). All patients presented with extranodal and often subcutaneous solid tumors. Laboratory features included elevated LDH and beta-2 microglobulin levels, monoclonal gammopathy, and EBV positivity of the tumor. Unlike conventional multiple myeloma, patients had normal calcium levels and only mild anemia. Six patients who have completed treatment achieved complete responses with radiation therapy and/or reduction in immunosuppression with two patients now greater than 5 years in continuous complete response. Plasmacytic PTLD, despite its plasmacytic histology, is responsive to conventional therapies used for B-cell PTLD including reduction in immunosuppression and radiation therapy.”;}i:2;O:8:”stdClass”:4:{s:4:”type”;s:6:”Online”;s:4:”date”;s:10:”03/17/2011″;s:3:”url”;s:44:”https://www.ncbi.nlm.nih.gov/pubmed/21384506″;s:8:”abstract”;s:1852:”Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data. The improved life expectancy of patients with cystic fibrosis (CF) has led to a change in the impact of liver disease on the prognosis of this population. Liver transplantation has emerged as the procedure of choice for patients with CF and features of hepatic decompensation and for intractable variceal bleeding as a major manifestation. We retrospectively reviewed the United Network for Organ Sharing database to analyze the outcomes of 55 adults and 148 children with CF who underwent liver transplantation, and we compared them to patients who underwent transplantation for other etiologies. We additionally compared the benefits of liver transplantation among patients who underwent transplantation for cystic fibrosis-related liver disease (CFLD) and those who remained on the waiting list. The 5-year survival rates for children and adults undergoing liver transplantation were 85.8% and 72.7%, respectively (P = 0.016). A multivariate Cox regression analysis comparing pediatric and adult CF patients to patients who underwent transplantation for other etiologies noted lower 5-year survival rates (P < 0.0001). However, compared to those remaining on the waiting list, pediatric transplant recipients with CF (hazard ratio = 0.33, 95% confidence interval = 0.16-0.70, P = 0.004) and adult transplant recipients with CF (hazard ratio = 0.25, 95% confidence interval = 0.11-0.57, P = 0.001) gained a significant survival benefit. In conclusion, long-term outcomes in patients with CFLD are acceptable but are inferior in comparison with the outcomes of those undergoing transplantation for other etiologies. Despite such observations, a survival benefit was noted in transplant patients versus those who remained on the waiting list.”;}i:3;O:8:”stdClass”:4:{s:4:”type”;s:6:”Online”;s:4:”date”;s:10:”09/13/2007″;s:3:”url”;s:44:”https://www.ncbi.nlm.nih.gov/pubmed/17763405″;s:8:”abstract”;s:2025:”Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. It is widely perceived that outcomes are relatively poor following retransplantation (reTX) for recurrent of hepatitis C virus (HCV) infection. Transplant centers debate the utility of offering another liver to these patients. A U.S. study group was formed to retrospectively compare survival after reTX in patients with recurrent HCV (histologically proven) and those transplanted for other indications greater than 90 days after first transplantation, from 1996 to 2004. Patients were divided into 3 groups; group 1: HCV reTX (n = 43), group 2: non-HCV reTX (n = 73), and group 3: recurrent HCV but no reTX (n = 156). They were predominantly male, Caucasian, with mean age of 47.2 yr. The commonest indications for non-HCV reTX were chronic rejection (36%), hepatic artery thrombosis (31%) and recurrent primary sclerosing cholangitis (17%). Duration of hospitalization, number of intensive care unit (ICU) days, and time interval from listing to transplantation or reTX were similar between reTX groups. The 1-yr and 3-yr survival rates after reTX were also similar for HCV reTX and non-HCV reTX groups (1 yr, 69% vs. 73%; 3 yr, 49% vs. 55%). Model for End-Stage Liver Disease (MELD) scores were not predictive of survival from reTX. However, with a MELD score of >30 in the non HCV group, survival was <50%. In the recurrent HCV not undergoing reTX group, 30% were reevaluated for reTX but only 15% were listed for reTX and the 3-yr survival was 47%. The most common reasons for not listing for reTX were recurrent HCV within 6 months (22%), fibrosing cholestatic hepatitis (19%), and renal dysfunction (9%). In conclusion, patients retransplanted for recurrent HCV had similar 1-yr and 3-yr survival when compared to patients undergoing reTX for other indications. MELD scores were not predictive of post-reTX survival. Survival was 30. Many patients with recurrent HCV are not considered for reTX and die from recurrent disease.”;}i:4;O:8:”stdClass”:4:{s:4:”type”;s:6:”Online”;s:4:”date”;s:10:”05/14/2006″;s:3:”url”;s:44:”https://www.ncbi.nlm.nih.gov/pubmed/16718826″;s:8:”abstract”;s:1425:”Successful aspiration and ethanol sclerosis of a large, symptomatic, simple liver cyst: case presentation and review of the literature. Simple liver cysts are congenital with a prevalence of 2.5%-4.25%. Imaging, whether by US, CT or MRI, is accurate in distinguishing simple cysts from other etiologies, including parasitic, neoplastic, duct-related, and traumatic cysts. Symptomatic simple liver cysts are rare, and the true frequency of symptoms is not known. Symptomatic simple liver cysts are predominantly large (> 4 cm), right-sided, and more common in women and older patients. The vast majority of simple hepatic cysts require no treatment or follow-up, though large cysts (> 4 cm) may be followed initially with serial imaging to ensure stability. Attribution of symptoms to a large simple cyst should be undertaken with caution, after alternative diagnoses have been excluded. Aspiration may be performed to test whether symptoms are due to the cyst; however, cyst recurrence should be expected. Limited experience with both laparoscopic deroofing and aspiration, followed by instillation of a sclerosing agent has demonstrated promising results for the treatment of symptomatic cysts. Here, we describe a patient with a large, symptomatic, simple liver cyst who experienced complete resolution of symptoms following cyst drainage and alcohol ablation, and we present a comprehensive review of the literature.”;}}s:18:”clinical_interests”;a:10:{i:0;O:8:”stdClass”:1:{s:4:”type”;s:11:”Colonoscopy”;}i:1;O:8:”stdClass”:1:{s:4:”type”;s:22:”Flexible Sigmoidoscopy”;}i:2;O:8:”stdClass”:1:{s:4:”type”;s:9:”Endoscopy”;}i:3;O:8:”stdClass”:1:{s:4:”type”;s:19:”Autoimmune Diseases”;}i:4;O:8:”stdClass”:1:{s:4:”type”;s:9:”Cirrhosis”;}i:5;O:8:”stdClass”:1:{s:4:”type”;s:19:”Esophageal Diseases”;}i:6;O:8:”stdClass”:1:{s:4:”type”;s:10:”Hepatology”;}i:7;O:8:”stdClass”:1:{s:4:”type”;s:14:”Liver Diseases”;}i:8;O:8:”stdClass”:1:{s:4:”type”;s:16:”Liver Transplant”;}i:9;O:8:”stdClass”:1:{s:4:”type”;s:9:”Hepatitis”;}}s:9:”locations”;a:4:{i:0;O:8:”stdClass”:20:{s:4:”name”;s:38:”MedStar Georgetown University Hospital”;s:10:”primary_id”;s:4:”MGUH”;s:7:”primary”;b:1;s:21:”performing_procedures”;b:0;s:13:”sees_patients”;s:11:”accepts_new”;s:5:”phone”;O:8:”stdClass”:2:{s:5:”voice”;s:0:””;s:3:”fax”;s:0:””;}s:12:”availability”;a:3:{s:8:”weekdays”;b:0;s:8:”weekends”;b:0;s:8:”evenings”;b:0;}s:25:”subsite_index_association”;b:1;s:15:”hospital_titles”;a:0:{}s:8:”Address1″;s:22:”3800 Reservoir Road NW”;s:8:”Address2″;N;s:4:”City”;s:10:”Washington”;s:5:”State”;s:2:”DC”;s:10:”PostalCode”;s:5:”20007″;s:5:”Phone”;a:2:{s:5:”Voice”;N;s:3:”Fax”;N;}s:7:”Country”;s:2:”US”;s:9:”CustomUrl”;s:11:”/georgetown”;s:16:”Parent_PrimaryId”;s:3:”MSH”;s:8:”Latitude”;d:38.912081700000002;s:9:”Longitude”;d:-77.075299200000003;}i:1;O:8:”stdClass”:20:{s:4:”name”;s:21:”Physician Office 6845″;s:10:”primary_id”;s:4:”6845″;s:7:”primary”;b:1;s:21:”performing_procedures”;b:1;s:13:”sees_patients”;s:11:”accepts_new”;s:5:”phone”;O:8:”stdClass”:2:{s:5:”voice”;s:14:”(202) 444-3704″;s:3:”fax”;s:14:”(877) 680-8193″;}s:12:”availability”;a:3:{s:8:”weekdays”;b:0;s:8:”weekends”;b:0;s:8:”evenings”;b:0;}s:25:”subsite_index_association”;b:0;s:15:”hospital_titles”;a:0:{}s:8:”Address1″;s:23:”3800 Reservoir Road, NW”;s:8:”Address2″;s:39:”Pasquerilla Healthcare Center 2nd Floor”;s:4:”City”;s:10:”Washington”;s:5:”State”;s:2:”DC”;s:10:”PostalCode”;s:5:”20007″;s:5:”Phone”;a:2:{s:5:”Voice”;s:12:”202-444-3704″;s:3:”Fax”;s:12:”877-680-8193″;}s:7:”Country”;s:2:”US”;s:9:”CustomUrl”;N;s:16:”Parent_PrimaryId”;s:5:”MSHMD”;s:8:”Latitude”;d:38.912081700000002;s:9:”Longitude”;d:-77.075299200000003;}i:2;O:8:”stdClass”:20:{s:4:”name”;s:38:”MedStar Franklin Square Medical Center”;s:10:”primary_id”;s:5:”MFSMC”;s:7:”primary”;b:0;s:21:”performing_procedures”;b:1;s:13:”sees_patients”;s:11:”accepts_new”;s:5:”phone”;O:8:”stdClass”:2:{s:5:”voice”;s:14:”(443) 777-2475″;s:3:”fax”;s:0:””;}s:12:”availability”;a:3:{s:8:”weekdays”;b:1;s:8:”weekends”;b:0;s:8:”evenings”;b:0;}s:25:”subsite_index_association”;b:1;s:15:”hospital_titles”;a:0:{}s:8:”Address1″;s:26:”9000 Franklin Square Drive”;s:8:”Address2″;N;s:4:”City”;s:9:”Baltimore”;s:5:”State”;s:2:”MD”;s:10:”PostalCode”;s:5:”21237″;s:5:”Phone”;a:2:{s:5:”Voice”;N;s:3:”Fax”;N;}s:7:”Country”;s:2:”US”;s:9:”CustomUrl”;s:9:”/franklin”;s:16:”Parent_PrimaryId”;s:3:”MSH”;s:8:”Latitude”;d:39.350596199999998;s:9:”Longitude”;d:-76.479891899999998;}i:3;O:8:”stdClass”:20:{s:4:”name”;s:21:”Physician Office 7577″;s:10:”primary_id”;s:4:”7577″;s:7:”primary”;b:0;s:21:”performing_procedures”;b:1;s:13:”sees_patients”;s:11:”accepts_new”;s:5:”phone”;O:8:”stdClass”:2:{s:5:”voice”;s:14:”(443) 777-2475″;s:3:”fax”;s:0:””;}s:12:”availability”;a:3:{s:8:”weekdays”;b:0;s:8:”weekends”;b:0;s:8:”evenings”;b:0;}s:25:”subsite_index_association”;b:1;s:15:”hospital_titles”;a:0:{}s:8:”Address1″;s:26:”9000 Franklin Square Drive”;s:8:”Address2″;s:28:”Center for Digestive Disease”;s:4:”City”;s:9:”Baltimore”;s:5:”State”;s:2:”MD”;s:10:”PostalCode”;s:5:”21237″;s:5:”Phone”;a:2:{s:5:”Voice”;s:12:”443-777-2475″;s:3:”Fax”;s:12:”443-777-6362″;}s:7:”Country”;s:2:”US”;s:9:”CustomUrl”;N;s:16:”Parent_PrimaryId”;s:5:”MSHMD”;s:8:”Latitude”;d:39.350596199999998;s:9:”Longitude”;d:-76.479891899999998;}}s:10:”insurances”;a:55:{i:0;O:8:”stdClass”:4:{s:4:”name”;s:120:”QUVUTkEgLS0gQWV0bmEgRWxlY3QgQ2hvaWNlLyBFUE8gKEFldG5hIEhlYWx0aCBGdW5kKSBJbm5vdmF0aW9uIEhlYWx0aDogTmV0d29yayBPbmx5IFBsdXM=”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:108:”QWV0bmEgRWxlY3QgQ2hvaWNlLyBFUE8gKEFldG5hIEhlYWx0aCBGdW5kKSBJbm5vdmF0aW9uIEhlYWx0aDogTmV0d29yayBPbmx5IFBsdXM=”;s:17:”system_maintained”;b:0;}i:1;O:8:”stdClass”:4:{s:4:”name”;s:120:”QUVUTkEgLS0gQWV0bmEgRWxlY3QgQ2hvaWNlLyBPcGVuIEFjY2VzcyAoUE9TKSAgSW5ub3ZhdGlvbiBIZWFsdGg6IE9wZW4gTmV0d29yayBPbmx5IFBsdXM=”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:108:”QWV0bmEgRWxlY3QgQ2hvaWNlLyBPcGVuIEFjY2VzcyAoUE9TKSAgSW5ub3ZhdGlvbiBIZWFsdGg6IE9wZW4gTmV0d29yayBPbmx5IFBsdXM=”;s:17:”system_maintained”;b:0;}i:2;O:8:”stdClass”:4:{s:4:”name”;s:124:”QUVUTkEgLS0gQWV0bmEgSE1PICBTZWxlY3QgSE1PL0hlYWx0aEZ1bmQvSGVhbHRoIE5ldHdvcmsgIEFldG5hIElubm92YXRpb25zOiBITU8gJiBFUE8gUGx1cw==”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:112:”QWV0bmEgSE1PICBTZWxlY3QgSE1PL0hlYWx0aEZ1bmQvSGVhbHRoIE5ldHdvcmsgIEFldG5hIElubm92YXRpb25zOiBITU8gJiBFUE8gUGx1cw==”;s:17:”system_maintained”;b:0;}i:3;O:8:”stdClass”:4:{s:4:”name”;s:192:”QUVUTkEgLS0gQWV0bmEgSE1PLU9wZW4gQWNjZXNzL1NlbGVjdCBPQS9IZWFsdGhGdW5kL0hlYWx0aCBOZXR3b3JrIE9wdGlvbiBPQSAgSW5ub3ZhdGlvbiBIZWFsdGg6IFBPUyAgT3BlbiBITU8gIE9wb2VuIEhNTyBPcHRpb24gIE9wZW4gRVBPIFBsdXM=”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:180:”QWV0bmEgSE1PLU9wZW4gQWNjZXNzL1NlbGVjdCBPQS9IZWFsdGhGdW5kL0hlYWx0aCBOZXR3b3JrIE9wdGlvbiBPQSAgSW5ub3ZhdGlvbiBIZWFsdGg6IFBPUyAgT3BlbiBITU8gIE9wb2VuIEhNTyBPcHRpb24gIE9wZW4gRVBPIFBsdXM=”;s:17:”system_maintained”;b:0;}i:4;O:8:”stdClass”:4:{s:4:”name”;s:88:”QUVUTkEgLS0gQWV0bmEgTWFuYWdlZCBDaG9pY2UgKFBPUykgIElubm92YXRpb24gSGVhbHRoOiBQT1MgUGx1cw==”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:76:”QWV0bmEgTWFuYWdlZCBDaG9pY2UgKFBPUykgIElubm92YXRpb24gSGVhbHRoOiBQT1MgUGx1cw==”;s:17:”system_maintained”;b:0;}i:5;O:8:”stdClass”:4:{s:4:”name”;s:164:”QUVUTkEgLS0gQWV0bmEgTWFuYWdlZCBDaG9pY2UgT3BlbiBBY2Nlc3MgKFBPUykgIENob2ljZSBQT1MgJiBDaG9pY2UgUE9TIElJICBJbm5vdmF0aW9uIEhlYWx0aDogT3BlbiBQT1MgUGx1cyAgT3BlbiBQT1MgSUk=”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:152:”QWV0bmEgTWFuYWdlZCBDaG9pY2UgT3BlbiBBY2Nlc3MgKFBPUykgIENob2ljZSBQT1MgJiBDaG9pY2UgUE9TIElJICBJbm5vdmF0aW9uIEhlYWx0aDogT3BlbiBQT1MgUGx1cyAgT3BlbiBQT1MgSUk=”;s:17:”system_maintained”;b:0;}i:6;O:8:”stdClass”:4:{s:4:”name”;s:68:”QUVUTkEgLS0gQWV0bmEgTWVkaWNhcmUgQWR2YW50YWdlIEhNTyAmIFBQTyBQbGFucw==”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:56:”QWV0bmEgTWVkaWNhcmUgQWR2YW50YWdlIEhNTyAmIFBQTyBQbGFucw==”;s:17:”system_maintained”;b:0;}i:7;O:8:”stdClass”:4:{s:4:”name”;s:76:”QUVUTkEgLS0gQWV0bmEgT3BlbiBDaG9pY2UgKFBQTykgIElubm92YXRpb24gSGVhbHRoOiBQUE8=”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:64:”QWV0bmEgT3BlbiBDaG9pY2UgKFBQTykgIElubm92YXRpb24gSGVhbHRoOiBQUE8=”;s:17:”system_maintained”;b:0;}i:8;O:8:”stdClass”:4:{s:4:”name”;s:60:”QUVUTkEgLS0gQWV0bmEgUXVhbGl0eSBQb2ludCBvZiBTZXJ2aWNlIChQT1Mp”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:48:”QWV0bmEgUXVhbGl0eSBQb2ludCBvZiBTZXJ2aWNlIChQT1Mp”;s:17:”system_maintained”;b:0;}i:9;O:8:”stdClass”:4:{s:4:”name”;s:52:”QUVUTkEgLS0gQWV0bmEgU3R1ZGVudCBIZWFsdGggSW5zdXJhbmNl”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:40:”QWV0bmEgU3R1ZGVudCBIZWFsdGggSW5zdXJhbmNl”;s:17:”system_maintained”;b:0;}i:10;O:8:”stdClass”:4:{s:4:”name”;s:92:”QUVUTkEgLS0gQWV0bmEgVHJhZGl0aW9uYWwgQ2hvaWNlIChQUE8pICBJbm5vdmF0aW9uIEhlYWx0aDogSW5kZW1uaXR5″;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:80:”QWV0bmEgVHJhZGl0aW9uYWwgQ2hvaWNlIChQUE8pICBJbm5vdmF0aW9uIEhlYWx0aDogSW5kZW1uaXR5″;s:17:”system_maintained”;b:0;}i:11;O:8:”stdClass”:4:{s:4:”name”;s:40:”QUVUTkEgLS0gQWV0bmEgVVNBY2Nlc3MgKFBPUyk=”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:28:”QWV0bmEgVVNBY2Nlc3MgKFBPUyk=”;s:17:”system_maintained”;b:0;}i:12;O:8:”stdClass”:4:{s:4:”name”;s:60:”QUVUTkEgLS0gQWV0bmEgV29ya2VyJ3MgQ29tcGVuc2F0aW9uIE5ldHdvcms=”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:48:”QWV0bmEgV29ya2VyJ3MgQ29tcGVuc2F0aW9uIE5ldHdvcms=”;s:17:”system_maintained”;b:0;}i:13;O:8:”stdClass”:4:{s:4:”name”;s:48:”Q0FSRUZJUlNUIC0tIENGQkNCUyAoTkNBKSBJbmRlbW5pdHk=”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:32:”Q0ZCQ0JTIChOQ0EpIEluZGVtbml0eQ==”;s:17:”system_maintained”;b:0;}i:14;O:8:”stdClass”:4:{s:4:”name”;s:168:”Q0FSRUZJUlNUIC0tIENGQkNCUyBCbHVlIENob2ljZSBPcHQgT3V0IE9wZW4gQWNjZXNzICAgQmx1ZUNob2ljZSBPcGVuIEFjY2VzcyAgQmx1ZSBDaG9pY2UgQWR2YW50YWdlICAmIEhlYWx0aHkgQmx1ZSAoSE1PICBQT1Mp”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:152:”Q0ZCQ0JTIEJsdWUgQ2hvaWNlIE9wdCBPdXQgT3BlbiBBY2Nlc3MgICBCbHVlQ2hvaWNlIE9wZW4gQWNjZXNzICBCbHVlIENob2ljZSBBZHZhbnRhZ2UgICYgSGVhbHRoeSBCbHVlIChITU8gIFBPUyk=”;s:17:”system_maintained”;b:0;}i:15;O:8:”stdClass”:4:{s:4:”name”;s:84:”Q0FSRUZJUlNUIC0tIENGQkNCUyBCbHVlIENob2ljZSBPcHQgT3V0IFBsdXMgT3BlbiBBY2Nlc3MgKFBPUyk=”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:68:”Q0ZCQ0JTIEJsdWUgQ2hvaWNlIE9wdCBPdXQgUGx1cyBPcGVuIEFjY2VzcyAoUE9TKQ==”;s:17:”system_maintained”;b:0;}i:16;O:8:”stdClass”:4:{s:4:”name”;s:48:”Q0FSRUZJUlNUIC0tIENGQkNCUyBCbHVlQ2hvaWNlIEhNTw==”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:28:”Q0ZCQ0JTIEJsdWVDaG9pY2UgSE1P”;s:17:”system_maintained”;b:0;}i:17;O:8:”stdClass”:4:{s:4:”name”;s:84:”Q0FSRUZJUlNUIC0tIENGQkNCUyBGZWRlcmFsIEVtcGxveWVlIFByb2dyYW0gKFN0ZC4gJiBCYXNpYyBQUE8p”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:68:”Q0ZCQ0JTIEZlZGVyYWwgRW1wbG95ZWUgUHJvZ3JhbSAoU3RkLiAmIEJhc2ljIFBQTyk=”;s:17:”system_maintained”;b:0;}i:18;O:8:”stdClass”:4:{s:4:”name”;s:80:”Q0FSRUZJUlNUIC0tIENGQkNCUyBNYXJ5bGFuZCAgUG9pbnQgb2YgU2VydmljZSBQbGFuIChNUE9TKQ==”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:60:”Q0ZCQ0JTIE1hcnlsYW5kICBQb2ludCBvZiBTZXJ2aWNlIFBsYW4gKE1QT1Mp”;s:17:”system_maintained”;b:0;}i:19;O:8:”stdClass”:4:{s:4:”name”;s:60:”Q0FSRUZJUlNUIC0tIENGQkNCUyBNYXJ5bGFuZCBJbmRlbW5pdHkgb3IgUFBP”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:44:”Q0ZCQ0JTIE1hcnlsYW5kIEluZGVtbml0eSBvciBQUE8=”;s:17:”system_maintained”;b:0;}i:20;O:8:”stdClass”:4:{s:4:”name”;s:76:”Q0FSRUZJUlNUIC0tIENGQlNCQyBCbHVlIFByZWZlcnJlZCBQUE8gIEhlYWx0aHlCbHVlIFBQTw==”;s:4:”plan”;s:12:”Q0FSRUZJUlNU”;s:7:”product”;s:56:”Q0ZCU0JDIEJsdWUgUHJlZmVycmVkIFBQTyAgSGVhbHRoeUJsdWUgUFBP”;s:17:”system_maintained”;b:0;}i:21;O:8:”stdClass”:4:{s:4:”name”;s:88:”Q0lHTkEgSEVBTFRIIENBUkUgLS0gQ0lHTkEgRVBPICBQUE8gYW5kIFBQTyBQbHVzICBDaG9pY2UgRnVuZCBQUE8=”;s:4:”plan”;s:24:”Q0lHTkEgSEVBTFRIIENBUkU=”;s:7:”product”;s:60:”Q0lHTkEgRVBPICBQUE8gYW5kIFBQTyBQbHVzICBDaG9pY2UgRnVuZCBQUE8=”;s:17:”system_maintained”;b:0;}i:22;O:8:”stdClass”:4:{s:4:”name”;s:64:”Q0lHTkEgSEVBTFRIIENBUkUgLS0gQ0lHTkEgSE1PICYgTmV0d29yayAoSE1PKQ==”;s:4:”plan”;s:24:”Q0lHTkEgSEVBTFRIIENBUkU=”;s:7:”product”;s:36:”Q0lHTkEgSE1PICYgTmV0d29yayAoSE1PKQ==”;s:17:”system_maintained”;b:0;}i:23;O:8:”stdClass”:4:{s:4:”name”;s:104:”Q0lHTkEgSEVBTFRIIENBUkUgLS0gQ0lHTkEgSE1PIE9wZW4gQWNjZXNzIChPQSkgIE5ldHdvcmsgT0EgIFBPUyBPQSAmIE9BIFBsdXM=”;s:4:”plan”;s:24:”Q0lHTkEgSEVBTFRIIENBUkU=”;s:7:”product”;s:76:”Q0lHTkEgSE1PIE9wZW4gQWNjZXNzIChPQSkgIE5ldHdvcmsgT0EgIFBPUyBPQSAmIE9BIFBsdXM=”;s:17:”system_maintained”;b:0;}i:24;O:8:”stdClass”:4:{s:4:”name”;s:48:”Q0lHTkEgSEVBTFRIIENBUkUgLS0gQ0lHTkEgSW5kZW1uaXR5″;s:4:”plan”;s:24:”Q0lHTkEgSEVBTFRIIENBUkU=”;s:7:”product”;s:20:”Q0lHTkEgSW5kZW1uaXR5″;s:17:”system_maintained”;b:0;}i:25;O:8:”stdClass”:4:{s:4:”name”;s:56:”Q0lHTkEgSEVBTFRIIENBUkUgLS0gQ0lHTkEgUE9TL05ldHdvcmsgUE9T”;s:4:”plan”;s:24:”Q0lHTkEgSEVBTFRIIENBUkU=”;s:7:”product”;s:28:”Q0lHTkEgUE9TL05ldHdvcmsgUE9T”;s:17:”system_maintained”;b:0;}i:26;O:8:”stdClass”:4:{s:4:”name”;s:72:”Q0lHTkEgSEVBTFRIIENBUkUgLS0gR3JlYXQtV2VzdCBIZWFsdGhjYXJlIFBPUy9DSUdOQQ==”;s:4:”plan”;s:24:”Q0lHTkEgSEVBTFRIIENBUkU=”;s:7:”product”;s:44:”R3JlYXQtV2VzdCBIZWFsdGhjYXJlIFBPUy9DSUdOQQ==”;s:17:”system_maintained”;b:0;}i:27;O:8:”stdClass”:4:{s:4:”name”;s:92:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUksgLS0gQ292ZW50cnkgSGVhbHRoIENhcmUgTmF0aW9uYWwgTmV0d29yayBQUE8=”;s:4:”plan”;s:32:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUks=”;s:7:”product”;s:56:”Q292ZW50cnkgSGVhbHRoIENhcmUgTmF0aW9uYWwgTmV0d29yayBQUE8=”;s:17:”system_maintained”;b:0;}i:28;O:8:”stdClass”:4:{s:4:”name”;s:80:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUksgLS0gQ292ZW50cnkgSGVhbHRoIENhcmUgb2YgVmlyZ2luaWE=”;s:4:”plan”;s:32:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUks=”;s:7:”product”;s:44:”Q292ZW50cnkgSGVhbHRoIENhcmUgb2YgVmlyZ2luaWE=”;s:17:”system_maintained”;b:0;}i:29;O:8:”stdClass”:4:{s:4:”name”;s:76:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUksgLS0gQ292ZW50cnkgb2YgRGVsYXdhcmUgSE1PL1BQTw==”;s:4:”plan”;s:32:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUks=”;s:7:”product”;s:40:”Q292ZW50cnkgb2YgRGVsYXdhcmUgSE1PL1BQTw==”;s:17:”system_maintained”;b:0;}i:30;O:8:”stdClass”:4:{s:4:”name”;s:60:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUksgLS0gRmlyc3QgSGVhbHRoIFBQTw==”;s:4:”plan”;s:32:”Q09WRU5UUlkgSEVBTFRIIE5FVFdPUks=”;s:7:”product”;s:24:”Rmlyc3QgSGVhbHRoIFBQTw==”;s:17:”system_maintained”;b:0;}i:31;O:8:”stdClass”:4:{s:4:”name”;s:60:”RklSU1QgSEVBTFRIIChOT1cgQ09WRU5UUlkpIC0tIEZJUlNUIEhFQUxUSA==”;s:4:”plan”;s:36:”RklSU1QgSEVBTFRIIChOT1cgQ09WRU5UUlkp”;s:7:”product”;s:16:”RklSU1QgSEVBTFRI”;s:17:”system_maintained”;b:0;}i:32;O:8:”stdClass”:4:{s:4:”name”;s:24:”TUVESUNBUkUgRkZTIC0tIA==”;s:4:”plan”;s:16:”TUVESUNBUkUgRkZT”;s:7:”product”;s:0:””;s:17:”system_maintained”;b:0;}i:33;O:8:”stdClass”:4:{s:4:”name”;s:96:”TUVEU1RBUiBGQU1JTFkgQ0hPSUNFIC0tIE1lZFN0YXIgRmFtaWx5IENob2ljZSAtIE1hcnlsYW5kIEhlYWx0aCBDaG9pY2U=”;s:4:”plan”;s:28:”TUVEU1RBUiBGQU1JTFkgQ0hPSUNF”;s:7:”product”;s:64:”TWVkU3RhciBGYW1pbHkgQ2hvaWNlIC0gTWFyeWxhbmQgSGVhbHRoIENob2ljZQ==”;s:17:”system_maintained”;b:0;}i:34;O:8:”stdClass”:4:{s:4:”name”;s:88:”TUVEU1RBUiBGQU1JTFkgQ0hPSUNFIC0tIE1lZFN0YXIgRmFtaWx5IENob2ljZS1EQyBIZWFsdGh5IEZhbWlsaWVz”;s:4:”plan”;s:28:”TUVEU1RBUiBGQU1JTFkgQ0hPSUNF”;s:7:”product”;s:56:”TWVkU3RhciBGYW1pbHkgQ2hvaWNlLURDIEhlYWx0aHkgRmFtaWxpZXM=”;s:17:”system_maintained”;b:0;}i:35;O:8:”stdClass”:4:{s:4:”name”;s:68:”TUVEU1RBUiBNRURJQ0FSRSBDSE9JQ0UgLS0gTWVkU3RhciBNZWRpY2FyZSBDaG9pY2U=”;s:4:”plan”;s:32:”TUVEU1RBUiBNRURJQ0FSRSBDSE9JQ0U=”;s:7:”product”;s:32:”TWVkU3RhciBNZWRpY2FyZSBDaG9pY2U=”;s:17:”system_maintained”;b:0;}i:36;O:8:”stdClass”:4:{s:4:”name”;s:44:”TUVEU1RBUiBTRUxFQ1QgLS0gTWVkU3RhciBTZWxlY3Q=”;s:4:”plan”;s:20:”TUVEU1RBUiBTRUxFQ1Q=”;s:7:”product”;s:20:”TWVkU3RhciBTZWxlY3Q=”;s:17:”system_maintained”;b:0;}i:37;O:8:”stdClass”:4:{s:4:”name”;s:112:”UFJJVkFURSBIRUFMVEhDQVJFIFNZU1RFTVMgIElOQy4gIChQSENTKSAtLSBQcml2YXRlIEhlYWx0aCBDYXJlIFN5c3RlbXMgKFBIQ1MpIChQUE8p”;s:4:”plan”;s:56:”UFJJVkFURSBIRUFMVEhDQVJFIFNZU1RFTVMgIElOQy4gIChQSENTKQ==”;s:7:”product”;s:56:”UHJpdmF0ZSBIZWFsdGggQ2FyZSBTeXN0ZW1zIChQSENTKSAoUFBPKQ==”;s:17:”system_maintained”;b:0;}i:38;O:8:”stdClass”:4:{s:4:”name”;s:48:”VFJJQ0FSRSAtLSBUcmljYXJlIEV4dHJhIChJbmRlbW5pdHkp”;s:4:”plan”;s:12:”VFJJQ0FSRQ==”;s:7:”product”;s:36:”VHJpY2FyZSBFeHRyYSAoSW5kZW1uaXR5KQ==”;s:17:”system_maintained”;b:0;}i:39;O:8:”stdClass”:4:{s:4:”name”;s:32:”VFJJQ0FSRSAtLSBUcmljYXJlIFByaW1l”;s:4:”plan”;s:12:”VFJJQ0FSRQ==”;s:7:”product”;s:20:”VHJpY2FyZSBQcmltZQ==”;s:17:”system_maintained”;b:0;}i:40;O:8:”stdClass”:4:{s:4:”name”;s:36:”VFJJQ0FSRSAtLSBUcmljYXJlIFN0YW5kYXJk”;s:4:”plan”;s:12:”VFJJQ0FSRQ==”;s:7:”product”;s:24:”VHJpY2FyZSBTdGFuZGFyZA==”;s:17:”system_maintained”;b:0;}i:41;O:8:”stdClass”:4:{s:4:”name”;s:76:”VFJJQ0FSRSAtLSBUcmljYXJlIGZvciBMaWZlIChNZWRpY2FyZSBTdXBwbGVtZW50YWwgUGxhbik=”;s:4:”plan”;s:12:”VFJJQ0FSRQ==”;s:7:”product”;s:60:”VHJpY2FyZSBmb3IgTGlmZSAoTWVkaWNhcmUgU3VwcGxlbWVudGFsIFBsYW4p”;s:17:”system_maintained”;b:0;}i:42;O:8:”stdClass”:4:{s:4:”name”;s:48:”VU5JVEVEIEhFQUxUSENBUkUgLS0gTS5ELiBJUEEgKEhNTyk=”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:20:”TS5ELiBJUEEgKEhNTyk=”;s:17:”system_maintained”;b:0;}i:43;O:8:”stdClass”:4:{s:4:”name”;s:60:”VU5JVEVEIEhFQUxUSENBUkUgLS0gTS5ELiBJUEEgUHJlZmVycmVkIChQT1Mp”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:32:”TS5ELiBJUEEgUHJlZmVycmVkIChQT1Mp”;s:17:”system_maintained”;b:0;}i:44;O:8:”stdClass”:4:{s:4:”name”;s:72:”VU5JVEVEIEhFQUxUSENBUkUgLS0gTWFtc2kgTGlmZSAmIEhlYWx0aCAoSW5kZW0uL1BQTyk=”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:44:”TWFtc2kgTGlmZSAmIEhlYWx0aCAoSW5kZW0uL1BQTyk=”;s:17:”system_maintained”;b:0;}i:45;O:8:”stdClass”:4:{s:4:”name”;s:52:”VU5JVEVEIEhFQUxUSENBUkUgLS0gT25lTmV0IFBQTyAgSW5jLg==”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:24:”T25lTmV0IFBQTyAgSW5jLg==”;s:17:”system_maintained”;b:0;}i:46;O:8:”stdClass”:4:{s:4:”name”;s:128:”VU5JVEVEIEhFQUxUSENBUkUgLS0gT3B0aW11bSBDaG9pY2UgIFVuaXRlZCBIZWFsdGhjYXJlIE5hdmlnYXRlICBVbml0ZWQgSGVhbHRoY2FyZSBDb21wYXNzIChITU8p”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:100:”T3B0aW11bSBDaG9pY2UgIFVuaXRlZCBIZWFsdGhjYXJlIE5hdmlnYXRlICBVbml0ZWQgSGVhbHRoY2FyZSBDb21wYXNzIChITU8p”;s:17:”system_maintained”;b:0;}i:47;O:8:”stdClass”:4:{s:4:”name”;s:96:”VU5JVEVEIEhFQUxUSENBUkUgLS0gT3B0aW11bSBDaG9pY2UgUHJlZmVycmVkIChQT1MpICYgT0NJIERpcmVjdCAoSE1PKQ==”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:68:”T3B0aW11bSBDaG9pY2UgUHJlZmVycmVkIChQT1MpICYgT0NJIERpcmVjdCAoSE1PKQ==”;s:17:”system_maintained”;b:0;}i:48;O:8:”stdClass”:4:{s:4:”name”;s:116:”VU5JVEVEIEhFQUxUSENBUkUgLS0gVW5pdGVkIEhlYWx0aGNhcmUgQ2hvaWNlICBVbml0ZWQgSGVhbHRoY2FyZSBDb3JlIEVzc2VudGlhbCAoSE1PKQ==”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:88:”VW5pdGVkIEhlYWx0aGNhcmUgQ2hvaWNlICBVbml0ZWQgSGVhbHRoY2FyZSBDb3JlIEVzc2VudGlhbCAoSE1PKQ==”;s:17:”system_maintained”;b:0;}i:49;O:8:”stdClass”:4:{s:4:”name”;s:68:”VU5JVEVEIEhFQUxUSENBUkUgLS0gVW5pdGVkIEhlYWx0aGNhcmUgQ2hvaWNlIFBsdXM=”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:40:”VW5pdGVkIEhlYWx0aGNhcmUgQ2hvaWNlIFBsdXM=”;s:17:”system_maintained”;b:0;}i:50;O:8:”stdClass”:4:{s:4:”name”;s:128:”VU5JVEVEIEhFQUxUSENBUkUgLS0gVW5pdGVkIEhlYWx0aGNhcmUgT3B0aW9ucyAoUFBPKSAoaW5jbHVkZXMgRW1waXJlIFBQTyAgR0VIQSAgQ29tcGFzcyBSb3NlKQ==”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:100:”VW5pdGVkIEhlYWx0aGNhcmUgT3B0aW9ucyAoUFBPKSAoaW5jbHVkZXMgRW1waXJlIFBQTyAgR0VIQSAgQ29tcGFzcyBSb3NlKQ==”;s:17:”system_maintained”;b:0;}i:51;O:8:”stdClass”:4:{s:4:”name”;s:80:”VU5JVEVEIEhFQUxUSENBUkUgLS0gVW5pdGVkIEhlYWx0aGNhcmUgU2VsZWN0IEhNTyAtIEVQTy9OUFA=”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:52:”VW5pdGVkIEhlYWx0aGNhcmUgU2VsZWN0IEhNTyAtIEVQTy9OUFA=”;s:17:”system_maintained”;b:0;}i:52;O:8:”stdClass”:4:{s:4:”name”;s:76:”VU5JVEVEIEhFQUxUSENBUkUgLS0gVW5pdGVkIEhlYWx0aGNhcmUgU2VsZWN0IFBsdXMgKFBPUyk=”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:48:”VW5pdGVkIEhlYWx0aGNhcmUgU2VsZWN0IFBsdXMgKFBPUyk=”;s:17:”system_maintained”;b:0;}i:53;O:8:”stdClass”:4:{s:4:”name”;s:60:”VU5JVEVEIEhFQUxUSENBUkUgLS0gVW5pdGVkIFN0dWRlbnQgUmVzb3VyY2Vz”;s:4:”plan”;s:24:”VU5JVEVEIEhFQUxUSENBUkU=”;s:7:”product”;s:32:”VW5pdGVkIFN0dWRlbnQgUmVzb3VyY2Vz”;s:17:”system_maintained”;b:0;}i:54;O:8:”stdClass”:4:{s:4:”name”;s:192:”QUVUTkEgLS0gQWV0bmEgSE1PLU9wZW4gQWNjZXNzL1NlbGVjdCBPQS9IZWFsdGhGdW5kL0hlYWx0aCBOZXR3b3JrIE9wdGlvbiBPQSAgSW5ub3ZhdGlvbiBIZWFsdGg6IFBPUyAgT3BlbiBITU8gIE9wZW4gSE1PIE9wdGlvbiAgT3BlbiBFUE8gUGx1cw==”;s:4:”plan”;s:8:”QUVUTkE=”;s:7:”product”;s:180:”QWV0bmEgSE1PLU9wZW4gQWNjZXNzL1NlbGVjdCBPQS9IZWFsdGhGdW5kL0hlYWx0aCBOZXR3b3JrIE9wdGlvbiBPQSAgSW5ub3ZhdGlvbiBIZWFsdGg6IFBPUyAgT3BlbiBITU8gIE9wZW4gSE1PIE9wdGlvbiAgT3BlbiBFUE8gUGx1cw==”;s:17:”system_maintained”;b:0;}}s:12:”profile_type”;s:2:”MD”;s:8:”old_echo”;O:7:”OldEcho”:4:{s:13:”IsPrimaryCare”;b:0;s:12:”IsPromptCare”;b:0;s:9:”is_select”;b:1;s:11:”IsPreferred”;b:1;}}